Andrew Spaventa is CEO at Singular Genomics Systems, Inc. (OMIC). They have made 5 open-market trades across 1 company since 2023, most recently 2025-02-21.
CIK 0001859701
1 open-market purchase totalling $49K since 2023, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OMIC | 1,432 | $29K |
Shares reported on the most recent Form 4, priced at the 2025-02-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OMIC | SELL | 2025-02-14 | 2025-02-14 | $19.89 | $16K | N/A | N/A | N/A |
| OMIC | SELL | 2024-12-16 | 2024-12-17 | $20.16 | $4K | -0.1% | +0.2% | N/A |
| OMIC | SELL | 2024-11-12 | 2024-11-13 | $22.55 | $16K | -6.6% | -12.6% | -12.9% |
| OMIC | SELL | 2024-09-15 | 2024-09-17 | $12.38 | $2K | -4.1% | -5.5% | +24.3% |
| OMIC | BUY | 2023-11-16 | 2023-11-20 | $0.42 | $49K | -1.9% | -3.8% | +24.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.